Today: 7 February 2026
Subscribe

ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

December 23, 2025 — Shares of ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) jumped Tuesday after the company disclosed that its board has received multiple competing proposals to acquire the company’s outstanding shares, escalating a strategic review that has been underway for months. ZIM Investors+2Benzinga+2 As of 17:15 UTC on Tuesday, Dec. 23, ZIM traded at $20.96, after touching an intraday high of $22.35 and low of $20.72 on unusually heavy volume. What’s driving the move is simple in headline form—“buyout proposals”—but the investor calculus is more complicated: ZIM sits at the intersection of (1) a potentially high-stakes corporate event
23 December 2025
··
NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

Dec. 23, 2025 — NexGen Energy Ltd. (TSX: NXE | NYSE: NXE | ASX: NXG) is back in the spotlight as investors weigh a familiar uranium-developer question with very unfamiliar stakes: how close is “close” to a construction decision? TMX Newsfile+1 For NexGen, that question largely funnels into one major catalyst: the Canadian Nuclear Safety Commission (CNSC) process for its 100%-owned Rook I Project in Saskatchewan’s uranium-rich Athabasca Basin. Part 1 of the CNSC hearing took place on Nov. 19, 2025, and Part 2 is scheduled for Feb. 9–13, 2026, after which the Commission will make its approval determination. Canadian
23 December 2025
·····
Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics Inc. (NASDAQ: GPCR) is ending 2025 in the middle of one of biotech’s hottest battlegrounds: oral weight-loss medicines. As of Dec. 23, 2025, GPCR shares were trading around $67.50 in U.S. session data, after a volatile stretch driven by blockbuster obesity-trial headlines, a major equity financing, and a wave of analyst price-target updates. Below is a comprehensive roundup of the latest news, forecasts, and analysis available as of 23.12.2025, and what investors are watching next. What is Structure Therapeutics, and why does GPCR trade like a headline detector? Structure Therapeutics is a clinical-stage biopharmaceutical company developing oral small-molecule
23 December 2025
····
Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck & Co., Inc. (NYSE: MRK) is closing in on year-end with a rare mix of policy-driven headlines, regulatory acceleration, and pipeline catalysts that are shaping investor expectations for 2026 and beyond. From a White House-backed drug-pricing framework that offers tariff relief to drugmakers, to the FDA’s fast-track voucher program attaching itself to two Merck assets with blockbuster potential, MRK stock is being evaluated not just on quarterly numbers—but on whether Merck can extend growth beyond Keytruda while navigating intensifying U.S. drug-pricing scrutiny. Reuters+2Reuters+2 Below is a comprehensive, publication-ready roundup of today’s MRK stock action, the key news moving the
23 December 2025
··
Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Corporation (NYSE: BAC) stock is trading near its recent highs as 2025 winds down, with investors balancing three big forces: a shifting interest-rate outlook, improving Wall Street deal momentum, and a growing stack of analyst upgrades heading into the bank’s next earnings report. As of Tuesday, December 23, 2025, BAC was trading around $55.96, modestly higher on the session, after touching an intraday high near $56.17. Investing.com Below is a full round-up of the latest news, forecasts, and market analysis available as of 23.12.2025, plus the key catalysts that could decide whether Bank of America stock breaks
23 December 2025
··
Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp (NASDAQ: HUT; TSX: HUT) is back in the market’s spotlight on December 23, 2025, as investors continue to re-rate the company less like a pure-play Bitcoin miner and more like a power-and-data-center platform for the AI era. The stock’s action has been anything but sleepy. After opening sharply lower, shares reversed higher and pushed into the low-to-mid $50s intraday. As of 17:04 UTC on Dec. 23, Hut 8 traded at $53.62, up 6.41% on the day, with an intraday range of $48.02 to $53.86 on roughly 6.7 million shares. So what’s driving the whiplash—and why are analysts
23 December 2025
···
Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Corporation (NASDAQ: INTC) is ending 2025 in a familiar place for long-time investors—right at the center of a high-stakes debate about what Intel is supposed to be. Is it a classic CPU giant fighting to regain product leadership? A U.S.-anchored foundry champion meant to rival TSMC? Or both at once? On Tuesday, Dec. 23, 2025, that identity question is colliding with a fresh wave of Wall Street calls, a closely watched Nvidia investment now cleared by U.S. antitrust agencies, and renewed arguments that Intel’s foundry ambitions may be limited by one simple issue: trust. Reuters+2Fudzilla+2 Intel stock price today:
23 December 2025
··
Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

December 23, 2025 — Lionsgate Studios Corp stock is having a loud day in the market. Shares of Lionsgate Studios Corp (NYSE: LION) traded around $9.06 Tuesday, up roughly 8%–9%, after touching an intraday high near $9.23 (and a low around $8.54). That price action matters because LION has been flirting with (and now pushing beyond) its prior 52-week high around $9.14—a technical milestone that tends to attract momentum traders and forces skeptics to revisit the “this is just a sleepy studio stock” thesis. Lionsgate Investors+1 Below is what’s new as of Dec. 23, 2025, plus the most relevant forecasts
23 December 2025
·
Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

December 23, 2025 — Eli Lilly and Company stock (NYSE: LLY) is holding near record territory as investors digest a fresh twist in the weight-loss drug race: the FDA has cleared Novo Nordisk’s first oral version of Wegovy, intensifying competition right as Lilly pushes its own once-daily pill candidate, orforglipron, toward a potential 2026 approval. As of 15:11 UTC on Tuesday, LLY traded around $1,077, slightly above the prior close, after moving between roughly $1,057 and $1,088 during the session. The backdrop is simple but powerful: the obesity market is expanding fast, and the “next chapter” is about convenience, supply,
23 December 2025
···
Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Dec. 23, 2025 — Citigroup, Inc. stock is closing out 2025 with a tailwind that investors have been waiting years to see: meaningful signs that long-running regulatory overhangs are starting to lift. Coming into Tuesday’s session, Citi (NYSE: C) was already riding fresh momentum after a strong Monday rally pushed the shares to a new 52‑week high. MarketWatch The year-end story around Citigroup stock is no longer just about a bank “in turnaround.” It’s increasingly about whether CEO Jane Fraser’s multi-year transformation is finally translating into a cleaner regulatory slate, a simpler operating model, and a clearer path to higher
23 December 2025
·
Novo Nordisk (NVO) Stock Jumps as FDA Approves Wegovy Weight-Loss Pill: Latest News, Forecasts, and What Investors Watch Next

Novo Nordisk (NVO) Stock Jumps as FDA Approves Wegovy Weight-Loss Pill: Latest News, Forecasts, and What Investors Watch Next

December 23, 2025 — Novo Nordisk A/S (NYSE: NVO) is back in the spotlight after U.S. regulators approved a pill version of Wegovy, a milestone that could reshape the fast-growing obesity drug market—and potentially reset the narrative around a stock that’s had a bruising 2025. In U.S. trading on Dec. 23, Novo Nordisk shares traded around $52, up roughly 9% on the day, as investors digested what the approval means for market share, pricing power, and the competitive race with Eli Lilly. Reuters What happened to Novo Nordisk stock on Dec. 23, 2025? Novo Nordisk’s rally was driven by a
23 December 2025
·
Costco Stock (COST) Outlook on Dec. 23, 2025: Earnings Beat, Holiday Spending Signals, and Wall Street Forecasts for 2026

Costco Stock (COST) Outlook on Dec. 23, 2025: Earnings Beat, Holiday Spending Signals, and Wall Street Forecasts for 2026

Costco Wholesale Corporation (NASDAQ: COST) is heading into the final stretch of 2025 in a familiar position operationally—strong sales, loyal members, and steady expansion—yet in a less familiar spot in the market: trading close to its 52‑week low after a year of choppy performance. As of Tuesday, Dec. 23, 2025, Costco shares were trading around $853 in late U.S. trading, up modestly on the day. StockAnalysis But the bigger story is the reset behind the scenes: even after Costco delivered a first‑quarter fiscal 2026 earnings beat and posted mid‑single‑digit comparable sales growth, the stock has faced questions about valuation, membership
23 December 2025
···
D-Wave Quantum Inc. (QBTS) Stock Today: CES 2026 Catalyst, Analyst Price Targets, and 2026 Outlook (Dec. 23, 2025)

D-Wave Quantum Inc. (QBTS) Stock Today: CES 2026 Catalyst, Analyst Price Targets, and 2026 Outlook (Dec. 23, 2025)

D-Wave Quantum Inc. (NYSE: QBTS) is back in the spotlight on December 23, 2025, after a headline-driven surge on Monday turned into a sharp cooldown on Tuesday—an all-too-familiar pattern for a high-volatility “pure-play” quantum computing stock. The trigger: D-Wave’s announcement that it will showcase commercial quantum technology at CES 2026, putting its pitch for real-world use cases in front of a mainstream tech audience. D-Wave Quantum+1 As of 11:37 a.m. ET (16:37 UTC) on Dec. 23, QBTS was trading at $30.09, down $2.10 (-6.5%) from the prior close, after swinging between an intraday high of $31.98 and a low of
23 December 2025
··
Polestar Automotive Holding UK PLC Stock (PSNY) Jumps as $300 Million BBVA–Natixis Funding Closes: Latest News, Forecasts and What’s Next

Polestar Automotive Holding UK PLC Stock (PSNY) Jumps as $300 Million BBVA–Natixis Funding Closes: Latest News, Forecasts and What’s Next

Polestar Automotive Holding UK PLC stock is back in traders’ headlights on Tuesday, December 23, 2025, after the company confirmed it closed a roughly $300 million funding transaction tied to European investment banks BBVA and Natixis—a rare “fresh cash in the door” moment for an EV maker that has spent much of 2025 battling liquidity anxiety. MarketScreener In U.S. trading on Dec. 23, PSNY changed hands around $15.37 with an intraday range of roughly $13.97–$15.60, extending a sharp multi-day move following last week’s financing announcements. That price action is the headline. The story underneath it is more complicated—and more interesting:
23 December 2025
··
CoreWeave Stock (NASDAQ: CRWV) News Today: Why Shares Are Moving, Latest AI Data-Center Catalysts, and Wall Street Forecasts (Dec. 23, 2025)

CoreWeave Stock (NASDAQ: CRWV) News Today: Why Shares Are Moving, Latest AI Data-Center Catalysts, and Wall Street Forecasts (Dec. 23, 2025)

CoreWeave, Inc. (NASDAQ: CRWV) stock is sliding in Tuesday’s session (Dec. 23, 2025) after an early gap down, underscoring just how volatile the “AI infrastructure” trade has become heading into year-end. As of the latest available data timestamp, CRWV was trading around $81.93, down roughly 3.4% on the day, after opening near $82.28 and touching an intraday low around $78.77. MarketBeat The move comes as investors weigh two competing narratives around CoreWeave: a backlog-and-demand story built on hyperscale AI compute contracts and expanding public-sector ambitions, versus a capital intensity story dominated by debt, dilution risk, and the timing of new
23 December 2025
Century Aluminum (CENX) Stock Climbs After Wells Fargo Raises Price Target to $46: News, Forecasts, and What to Watch on Dec. 23, 2025

Century Aluminum (CENX) Stock Climbs After Wells Fargo Raises Price Target to $46: News, Forecasts, and What to Watch on Dec. 23, 2025

Century Aluminum Company stock (NASDAQ: CENX) pushed higher on Tuesday, Dec. 23, after Wells Fargo boosted its 12‑month price target—adding fresh fuel to a rally that has increasingly been tied to one big theme: tight metal supply meeting tariff-driven price dislocations. Benzinga+2TipRanks+2 Below is the latest on today’s catalyst, the macro forces behind the move, what analysts are forecasting now, and the key company-specific drivers investors are watching into 2026. What’s driving Century Aluminum stock today The immediate spark is a Wells Fargo price-target increase to $46 from $37, while maintaining an Overweight rating. The firm’s thesis centers on supply
23 December 2025
·
Robinhood (HOOD) Stock News Today, Dec. 23, 2025: Prediction Markets Expansion, Analyst Forecasts, and the 2026 Outlook

Robinhood (HOOD) Stock News Today, Dec. 23, 2025: Prediction Markets Expansion, Analyst Forecasts, and the 2026 Outlook

Robinhood Markets, Inc. (NASDAQ: HOOD) is ending 2025 in the spotlight again—this time at the intersection of retail trading momentum, crypto-linked volatility, and a fast-growing push into prediction markets that looks increasingly like a new revenue engine. On Tuesday, December 23, 2025, HOOD shares traded lower, hovering around $119 and down roughly 2%–3% intraday after Monday’s close near $122. StockAnalysis The decline comes as crypto-related equities broadly softened alongside a pullback in Bitcoin. Barron’s Still, the bigger story is what investors are debating heading into 2026: whether Robinhood’s product expansion (especially event contracts), international growth plans, and scale economics can
23 December 2025
··
Regencell Bioscience (RGC) Stock Today: Price Surge Extends December Rally as DOJ Probe and “Going Concern” Risks Loom

Regencell Bioscience (RGC) Stock Today: Price Surge Extends December Rally as DOJ Probe and “Going Concern” Risks Loom

December 23, 2025 — Regencell Bioscience Holdings Limited (NASDAQ: RGC) is back in the spotlight on Tuesday after another sharp move higher, extending a volatile December run that’s pulled in momentum traders—and raised fresh questions about fundamentals, governance, and legal risk. As of late morning in U.S. trading, RGC was changing hands around the mid‑$23 range after opening higher, with the day’s trading range roughly $22.00–$23.99. StockAnalysis+1 Below is what’s driving the conversation around Regencell stock right now, based on the latest coverage and filings available on December 23, 2025. RGC stock jumps again on Dec. 23 as it trades
23 December 2025
Sandisk Corporation (SNDK) Stock: Latest News, Price Action, Analyst Forecasts and Key Catalysts for Dec. 23, 2025

Sandisk Corporation (SNDK) Stock: Latest News, Price Action, Analyst Forecasts and Key Catalysts for Dec. 23, 2025

Dec. 23, 2025 — Sandisk Corporation stock (Nasdaq: SNDK) is trading near the $240 level on Tuesday, keeping the company in the spotlight after one of the most dramatic post-spin rallies in the U.S. tech hardware universe this year. As of roughly 10:24 a.m. ET, SNDK was at $240.47, down $0.58 on the day, after moving between $234.18 and $243.41 in the session. Sandisk’s 2025 storyline has been defined by a powerful rebound in flash memory fundamentals—specifically NAND—colliding with exploding AI infrastructure demand, a still-cautious supply backdrop, and a market willing to pay up for “picks-and-shovels” capacity. That combination has
23 December 2025
HYMC Stock Surges on Vortex Silver Drill Results: Latest Hycroft Mining News, Outlook, and Forecast Catalysts for Dec. 23, 2025

HYMC Stock Surges on Vortex Silver Drill Results: Latest Hycroft Mining News, Outlook, and Forecast Catalysts for Dec. 23, 2025

December 23, 2025 — Hycroft Mining Holding Corporation (NASDAQ: HYMC) is having the kind of week that makes small-cap resource investors sit up, spill coffee, and suddenly remember how to spell “intercepts.” After a 49% surge on Monday and a fresh push toward a new 52-week high on Tuesday, HYMC stock is ripping higher on a double catalyst: company-specific high-grade silver drill results and a historic melt-up in precious metals prices. PR Newswire+2StockAnalysis+2 What follows is the full, up-to-date picture as of 23.12.2025—the headlines driving HYMC, what analysts and market commentary are emphasizing today, and the forward-looking milestones investors are
23 December 2025
··
1 … 779 780 781 782 783 … 1,631

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop